By STANFORD UNIVERSITY SCHOOL OF ENGINEERING Stanford engineers have developed an injectable hydrogel depot technology that enables GLP-1 drugs to be administered once every four months, compared to repeated daily injections. Credit: Photo courtesy of Andrea Ivana d’Aquino / Stanford University Innovations in Type 2 diabetes treatment have been revolutionized by dietary management drugs, although...